Agilent, GS96-CU, GlykoPrep cleanup module, 96-ct

GlykoPrep cleanup module, 96-ct. GlykoPrep N-glycan sample preparation is a cartridge based workflow. Module for cleanup of glycans from aqueous solution. Compatible with microplate liquid handling platforms. Designed for cleanup with the InstantDye labeling modules.

Specifications:
Count: 96
Equipment & Reagents Provided by User: Centrifuge with a deep-well plate rotor (minimum 44 mm height)Starter labware kit (AM200)
Kit Configuration: Sample Prep Module

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
The GlykoPrep cleanup module, 96-ct, is designed to streamline and standardize glycan sample preparation for high-throughput laboratories. This scalable solution enables efficient purification and cleanup of complex glycan samples from a wide range of biological matrices, ensuring reproducibility and superior sample quality. The 96-well format allows parallel processing of multiple samples, making it ideal for workflows requiring robust, reproducible results across clinical research, biopharmaceutical development, and academic glycomics studies. The module supports downstream analysis by LC, LC/MS, MALDI-MS, and HPLC when coupled with Agilent’s glycan labeling kits and analytical columns, providing seamless integration into existing workflows. Compatible with liquid handling workstations and automated platforms, this cleanup solution accelerates sample throughput and minimizes manual errors. It is particularly suited for applications such as monoclonal antibody characterization, glycoprotein profiling, and quality control in bioprocessing environments. Additionally, it works in conjunction with Agilent’s GlykoPrep sample preparation and glycan analysis products to ensure optimal glycan recovery and analytical performance. This module is a reliable, high-efficiency choice that delivers consistent results for researchers seeking to advance glycoscience and biotherapeutic development.